🤧 Flu Vaccine Antigenic Drift & Strain Selection Simulator
This model illustrates the annual drift of influenza virus antigens and the process by which the World Health Organization (WHO) selects strains for the seasonal vaccine, evaluating the match between the vaccine and circulating strains.
Antigenic Drift — Small Mutations Reshape the Flu Surface Every Season
Flu surface proteins slowly accumulate mutations each year.
- HA & NA: Surface proteins (Main antibody targets.)
- Continuous: Drift rate (Small changes every season.)
- Partial: Immune escape (Old antibodies bind less well.)
- RNA errors: Main driver (Polymerase lacks proofreading.)
Why the virus keeps changing shape
Placeholder: RNA polymerase errors accumulate, reshaping surface epitopes gradually.
Global Influenza Surveillance — Sampling the World Before Deciding
Labs worldwide send samples to WHO collaborating centers.
- GISRS: Network (WHO global surveillance system.)
- 100+: Countries (Contribute surveillance samples yearly.)
- Thousands: Samples analyzed (Sequenced and antigenically tested.)
- Genetic + antigenic: Data types (Sequence and antibody reaction data.)
Turning samples into a strain forecast
Placeholder: sequencing and ferret antisera testing map current variant spread.
The Strain Selection Meeting — Committing to a Guess Months Early
Committees meet each February and September to pick strains.
- Feb & Sept: Meeting dates (Northern and southern hemisphere.)
- 6–8 months: Lead time (Before vaccine reaches clinics.)
- 3–4: Strains chosen (Trivalent or quadrivalent formulas.)
- WHO panel: Decision body (Expert virologists vote on strains.)
Predicting future drift from current data
Placeholder: experts extrapolate trends to guess dominant strains months ahead.
From Selected Strain to Filled Vial — The Manufacturing Clock
Selected strains are grown in eggs or cells for months.
- ~6 months: Production time (Egg or cell-based growth.)
- Billions: Doses produced (Globally each flu season.)
- Multiple: Quality steps (Purity and potency testing.)
- Late summer: Distribution start (Ahead of flu season.)
Why manufacturing locks in the guess early
Placeholder: long production time forces early commitment to predicted strains.
Did the Guess Pay Off? Measuring Real-World Vaccine Match
Effectiveness depends on how much the virus drifted after selection.
- 40–60% VE: Good match years (When prediction holds well.)
- 10–30% VE: Mismatch years (When drift outpaces prediction.)
- Late drift: Mismatch cause (Change after strains are locked.)
- Ongoing: Monitoring (Mid-season effectiveness studies.)
Why some flu seasons see poor protection
Placeholder: extra drift after selection lowers real-world vaccine effectiveness.
Placeholder: closer surveillance and shorter lead times could improve match rates.
This model illustrates the annual drift of influenza virus antigens and the process by which the World Health Organization (WHO) selects strains for the seasonal vaccine, evaluating the match between the vaccine and circulating strains.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install